| 1 |
29132870 | mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation. | 2018 Feb |
1 |
| 2 |
29432811 | Rapamycin attenuates Th2-driven experimental allergic conjunctivitis. | 2018 May |
1 |
| 3 |
28729300 | Rapamycin is highly effective in murine models of immune-mediated bone marrow failure. | 2017 Oct |
1 |
| 4 |
25794646 | Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice. | 2015 Jun |
1 |
| 5 |
25867817 | iPSC-MSCs Combined with Low-Dose Rapamycin Induced Islet Allograft Tolerance Through Suppressing Th1 and Enhancing Regulatory T-Cell Differentiation. | 2015 Aug 1 |
1 |
| 6 |
18480312 | Differential effects of rapamycin in anti-GBM glomerulonephritis. | 2008 Aug |
1 |
| 7 |
16920556 | Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy. | 2006 Sep |
7 |
| 8 |
11872661 | Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. | 2002 Mar |
2 |
| 9 |
11935154 | Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice. | 2002 Feb |
2 |